Location History:
- London, GB (2003)
- Glasgow, GB (2000 - 2007)
Company Filing History:
Years Active: 2000-2007
Title: Mark Roberts: Innovator in Vaccine Development
Introduction
Mark Roberts is a distinguished inventor based in Glasgow, GB. He has made significant contributions to the field of vaccine development, holding a total of 4 patents. His work focuses on innovative approaches to enhance immune responses through novel vaccine compositions.
Latest Patents
One of his latest patents involves the use of non-toxic double mutant forms of pertussis toxin as adjuvants. This invention relates to the use of an antigen that is a non-toxic double mutant form of pertussis toxin for the manufacture of a vaccine composition intended for intranasal administration. The goal is to induce an immune response against infection. Additionally, this invention encompasses the use of a non-toxic double mutant form of pertussis toxin for creating an adjuvant composition that stimulates or enhances the protective immune response of an antigen co-administered with it. The preferred non-toxic double mutant includes a substitution of glutamic acid 129 with glycine and arginine 9 with lysine.
Another significant patent by Roberts focuses on vaccine compositions utilizing the Hepatitis A virus capsid or a mucosally immunogenic fragment or epitope thereof. This invention aims to manufacture a mucosal vaccine composition for administration to a mucosal surface of a patient, thereby inducing the production of serum Immunoglobulin G antibodies against Hepatitis A. The preferred method of administration for this vaccine composition is through the intranasal route.
Career Highlights
Throughout his career, Mark Roberts has worked with notable companies in the pharmaceutical industry, including Medeva Holdings BV and UCB Pharma GmbH. His experience in these organizations has contributed to his expertise in vaccine development and innovation.
Collaborations
Mark has collaborated with esteemed colleagues such as Steven Neville Chatfield and Gordon Dougan. These partnerships have further enriched his research and development efforts in the field of immunology.
Conclusion
Mark Roberts is a prominent inventor whose work in vaccine development has the potential to significantly impact public health. His innovative patents and collaborations reflect his commitment to advancing medical science and improving immune responses through effective vaccine strategies.